Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Children

So far, no pediatric doses for indinavir combined with ritonavir have been defined. This study evaluated the pharmacokinetics of 400 mg of indinavir/m(2) combined with 125 mg of ritonavir/m(2) every 12 h (q12h) in 14 human immunodeficiency virus type 1-infected children. The area under the concentra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Bergshoeff, A. S., Fraaij, P. L. A., van Rossum, A. M. C., Verweel, G., Wynne, L. H., Winchell, G. A., Leavitt, R. Y., Nguyen, B.-Y. T., de Groot, R., Burger, D. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2004
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400593/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105157/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1904-1907.2004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares